SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxons outlook for stronger refining margins is drawing attention as traders weigh the benefit to third-quarter results against lower oil prices drag on upstream earnings. Some interpret the filing as an earnings warning, while others point to the refining strength and the stocks approach to a 52-week high.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

GDX is drawing attention amid a volatile correction in gold miners, with traders pointing to gold weakness and rate and yield concerns as near-term pressure. The community is split between bearish calls for further downside and buyers treating the pullback as an opportunity, citing longer-term gold demand and inflation or debt concerns.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

A sharp semiconductor selloff, amid broader tech weakness, has put SMH in focus as traders weigh concerns about AI infrastructure financing and returns alongside inflation and higher-rate risks. Views are split between expecting further downside and treating the extended decline as an oversold buying opportunity.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubriks strong quarterly results and raised full-year outlook have been overshadowed by a post-earnings selloff, with traders citing high expectations and slower projected second-half cloud net-new ARR growth. Bulls view the pullback as profit-taking after a rally and point to continued demand, while bears question managements guidance and the companys valuation.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrows selloff is being attributed by traders to speculation that investor Opaleye may be unwinding its position, though the claims are unconfirmed. The discussion also centers on uncertainty about upcoming Q3 revenue and whether Harrow can execute on growth plans for VEVYE and IHEEZO; some investors see the weakness as a buying opportunity, while others remain frustrated by past execution and guidance misses.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLAs record-long losing streak is drawing attention amid weakness across semiconductor-equipment stocks, which traders partly blame on Applied Materials lack of concrete near-term wafer-fab spending guidance. Some see the pullback as a buying opportunity and argue KLAs business remains strong, while others are concerned about uncertain sector spending and continued downside.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

Northlands upgrade of C3.ai, citing its C3 Code platform for building agentic AI applications, is driving attention. Bullish traders point to the upgrade and possible short covering, while skeptics question whether the product can translate into growth amid weak revenue and volatile price action.

Flutter Entertainment Plc engages in the business of online betting and gaming. It operates through the following segments: UK and Ireland, Australia, International, and US. The UK and Ireland segment includes the operations of Sky Betting and Gaming, Paddy Power, Betfair, and tombola. The Australia segment focuses on sports betting services provided to Australian customers online. The International segment relates to poker, casino, rummy, lottery, and sports betting. The US segment includes sports betting, daily fantasy sports, and gaming services. The company was founded in 1988 and is headquartered in New York, NY.

Flutter Entertainment Plc

Flutter is drawing attention amid a steep selloff tied to Brazils online-betting restrictions and concerns that prediction markets are intensifying competition for sportsbooks. Traders debate whether the weakness is overdone, with some pointing to a recent Citi upgrade and possible FanDuel improvement ahead of Q3 results while others remain wary of regulatory and execution risks.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMCs record quarterly results and strong outlook have intensified discussion of AI-chip demand, but shares have fallen alongside a broader semiconductor selloff. Traders are debating whether the pullback is a buying opportunity or reflects concerns about rising investment, margin pressure from the 2nm ramp, and caution about the longer-term outlook.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

BKKT is drawing attention for its persistent selloff and repeated tests of lows, with traders frustrated that it has often underperformed even when Bitcoin and other crypto-linked stocks rise. The debate centers on whether its stablecoin and payments infrastructure pivot can deliver growth, or whether weak execution, dilution concerns and distrust of management will keep weighing on the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BCTX So according to management using present tense language with 177 already enrolled in each arm , the 354 total did truly Hockey stick as they previously stated. I think that went over the analysts head. This is now being driven by the control arm. Very likely management has a good feel for the expectations on the previous year end expectations. Since they said cash run through 2nd qtr and expenses drop rapidly in the observable stage of a trial , all we have to do is wait.

StockTwits for iOS

BriaCell Therapeutics Corp

 So according to management using present tense language with 177 already enrolled in each arm , the 354 total did truly Hockey stick as they previously stated. I think that went over the analysts head. This is now being driven by the control arm. Very likely management has a good feel for the expectations on the previous year end expectations. Since they said cash run through 2nd qtr and expenses drop rapidly in the observable stage of a trial , all we have to do is wait.

@Biotechlineup I sure hope so, I wish we knew the amount of patients of each subtype. If the Phase 3 population resembles the Phase 2 mix—about 61% HR-positive and 33% TNBC—then a blended chemo control group median around 8.5–9.5 months is reasonable. If TNBC is overrepresented, 7–8 months becomes more plausible. If HR-positive dominates heavily, it could be closer to 10–11 months. Which wouldn&#39;t be great towards hitting the HR of .60

StockTwits Web

 I sure hope so, I wish we knew the amount of patients of each subtype. If the Phase 3 population resembles the Phase 2 mix—about 61% HR-positive and 33% TNBC—then a blended chemo control group median around 8.5–9.5 months is reasonable. If TNBC is overrepresented, 7–8 months becomes more plausible. If HR-positive dominates heavily, it could be closer to 10–11 months. Which wouldn't be great towards hitting the HR of .60